US team improves breast-implant procedure:
This article was originally published in Clinica
Executive Summary
A new antibiotic solution could help reduce or prevent breast implants from hardening, a common risk associated with cosmetic and reconstructive breast-implant surgery that might cause pain and interfere with mammography. Developed by researchers from the University of Texas Southwestern Medical Center in Dallas, the solution inhibits all bacterial growth from organisms commonly found around breast implants. Early results from an ongoing 125-patient trial of the product have shown positive results, according to the team, which reported its findings in the January issue of Plastic and Reconstructive Surgery.
You may also be interested in...
GE HealthCare Launches AI-Powered Voluson Ultrasound For Women’s Health
Voluson Signature 20 and 18 ultrasound provides clinicians with workflow efficiencies in detecting female reproductive health problems, especially those related to pregnancy.
CDER, CBER Not Seeing Hiring Slowdown Despite US FDA Warnings
FDA officials have said hiring could be slowed if an inflationary pay increase is not included in the agency budget, but CDER and CBER continue to add staff at a steady pace.
Medicare Reimbursement For Part B Drugs Is 48% Above 340B Prices To Hospitals, MedPAC Finds
New study updates past commission analyses and highlights the significant margin between Medicare payments for drugs and the prices paid by 340B-eligible providers.